A novel mutation in DAX1 causes delayed-onset adrenal insufficiency and incomplete hypogonadotropic hypogonadism
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Mutations in the DAX1 gene cause X-linked adrenal hypoplasia congenita (AHC) and hypogonadotropic hypogonadism (HHG). In affected boys, primary adrenal insufficiency occurs soon after birth or during early childhood; HHG is recognized at the expected time of puberty. In this report, we describe the novel phenotype of a man who presented with apparently isolated adrenal insufficiency at 28 years of age. Examination revealed partial pubertal development and undiagnosed incomplete HHG. Gonadotropin therapy did not improve his marked oligospermia, suggesting a concomitant primary testicular abnormality. Genomic analysis revealed a novel missense mutation, I439S, in DAX1. The mutant DAX-1 protein was studied for its ability to function as a transcriptional repressor of target genes. Consistent with the patient's mild clinical phenotype, the I439S mutation conferred intermediate levels of repressor activity of DAX-1 when compared with mutations associated with classic AHC. This unique case extends the clinical spectrum of AHC to include delayed-onset primary adrenal insufficiency in adulthood and milder forms of HHG. Furthermore, in accordance with findings in Ahch (Dax1) knockout mice, the clinical features in this patient suggest that DAX-1 function is required for spermatogenesis in humans, independent of its known effects on gonadotropin production.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measurement of dimeric inhibin B throughout the human menstrual cycle
Groome, N. P. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.4.1401 · Cited by 946 · cited 1×
“Serum inhibin B was measured as described previously (14).”
MethodCluster analysis: a simple, versatile, and robust algorithm for endocrine pulse detection
Veldhuis, J. D., & Johnson, M. L. (1986) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1986.250.4.e486 · Cited by 861 · cited 1×
“LH and FAS pulsatility was determined using cluster analysis (method number 7)(15).”
MethodZanaria, E., Muscatelli, F., Bardoni, B., Strom, T. M., Guioli, S., Guo, W., Lalli, E., Moser, C., Walker, A. P., McCabe, E. R. B., et al. (1994) · Nature · doi:10.1038/372635a0 · Cited by 858 · cited 4×
“Discussion The discovery that mutations in the human nuclear receptor gene DAX1 give rise to both X-linked AHC and HHG (1, 11) has provided new insight into the pathogenesis of this syndrome.”
BackgroundInfluentialMuscatelli, F., Strom, T. M., Walker, A. P., Zanaria, E., Récan, D., Meindl, A., Bardoni, B., Guioli, S., Zehetner, G., Rabl, W., et al. (1994) · Nature · doi:10.1038/372672a0 · Cited by 767 · cited 8×
“Mutations in the DAX1 gene in humans cause the Xlinked cytomegalic form of adrenal hypoplasia congenita (AHC), a rare disorder characterized by impaired development of the permanent zone of the adrenal cortex and hypogonadotropic hypogonadism (HHG) (1, 11).”
BackgroundMethodInfluentialSteroidogenic factor 1: a key determinant of endocrine development and function
Parker, K. L., & Schimmer, B. P. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.3.0301 · Cited by 764 · cited 2×
“The coexpression of DAX-1 with SF-1 in the gonadal and adrenal axes (2, 3), and the adrenal failure seen in patients with mutations in these genes (11, 42), suggest that DAX-1 and SF-1 interact in a common genetic pathway.”
BackgroundAchermann, J. C., Ito, M., Ito, M., Hindmarsh, P. C., & Jameson, J. L. (1999) · Nature Genetics · doi:10.1038/9629 · Cited by 709 · cited 1×
“The coexpression of DAX-1 with SF-1 in the gonadal and adrenal axes (2, 3), and the adrenal failure seen in patients with mutations in these genes (11, 42), suggest that DAX-1 and SF-1 interact in a common genetic pathway.”
BackgroundSelf-citationA dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal
Bardoni, B., Zanaria, E., Guioli, S., Floridia, G., Worley, K. C., Tonini, G., Ferrante, E., Chiumello, G., McCabe, E. R. B., Fraccaro, M., et al. (1994) · Nature Genetics · doi:10.1038/ng0894-497 · Cited by 610
Wilms’ tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression.
Nachtigal, M. W., Hirokawa, Y., Enyeart-VanHouten, D. L., Flanagan, J. N., Hammer, G. D., & Ingraham, H. A. (1998) · Cell · doi:10.1016/s0092-8674(00)81172-1 · Cited by 591
Dax1 antagonizes Sry action in mammalian sex determination
Swain, A., Narvaez, V., Burgoyne, P., Camerino, G., & Lovell-Badge, R. (1998) · Nature · doi:10.1038/35799 · Cited by 550 · cited 1×
“This repression is compatible with the XY sex reversal seen in association with overexpression of Ahch/Dax1 in mice (45) and humans (46), where DAX-1 is thought to antagonize the actions of the testis-determination factor, SRY, in gonadal development.”
BackgroundA Dosage Sensitive Locus at Chromosome Xp21 Is Involved in Male to Female Sex Reversal
Bardoni, B., Zanaria, E., Guioli, S., Floridia, G., Worley, K. C., Tonini, G., Ferrante, E., Chiumello, G., McCabe, E. R. B., Fraccaro, M., et al. (1995) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199502000-00020 · Cited by 539 · cited 1×
“This repression is compatible with the XY sex reversal seen in association with overexpression of Ahch/Dax1 in mice (45) and humans (46), where DAX-1 is thought to antagonize the actions of the testis-determination factor, SRY, in gonadal development.”
BackgroundLee, S. L., Sadovsky, Y., Swirnoff, A. H., Polish, J. A., Goda, P., Gavrilina, G., & Milbrandt, J. (1996) · Science · doi:10.1126/science.273.5279.1219 · Cited by 480
Ito, M., Yu, R., & Jameson, J. L. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.3.1476 · Cited by 462 · cited 18×
“Wild-type DAX1 repressed this synergistic activation by 92%, whereas repression with the R267P, ∆V269, and ∆448–470 mutants ranged from 52% to 55%.”
BackgroundMethodResultInfluentialSelf-citationRole of Ahch in gonadal development and gametogenesis
Yu, R. N., Ito, M., Saunders, T. L., Camper, S. A., & Jameson., J. L. (1998) · Nature Genetics · doi:10.1038/3822 · Cited by 447 · cited 4×
“In addition, the low serum inhibin B concentration, despite a slightly elevated serum immunoreactive FSH concentration (41), provides further evidence that DAX-1 mutations cause primary defects in Sertoli cell function (10, 39).”
BackgroundInfluentialSelf-citationDNA binding and transcriptional repression by DAX-1 blocks steroidogenesis
Zazopoulos, E., Lalli, E., Stocco, D. M., & Sassone-Corsi, P. (1997) · Nature · doi:10.1038/36899 · Cited by 433 · cited 1×
“Indeed, DAX-1 also inhibits transcription of SF-1 target genes involved in adrenal steroidogenesis, such as steroidogenic acute regulatory protein (StAR), P450scc, and 3β-hydroxysteroid dehydrogenase (43, 44).”
BackgroundSeminara, S. B., Hayes, F. J., & Crowley, W. F. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.5.0344 · Cited by 414 · cited 4×
“It remains debatable whether HHG associated with DAX1 mutations results from hypothalamic or pituitary dysfunction (9, 12, 29, 34).”
BackgroundResultInfluentialNuclear Receptor DAX-1 Recruits Nuclear Receptor Corepressor N-CoR to Steroidogenic Factor 1
Crawford, P. A., Dorn, C., Sadovsky, Y., & Milbrandt, J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2949 · Cited by 338 · cited 2×
“As expected, wild-type DAX-1 exerted strong repression of basal transcriptional activity (6), SF-1 mediated transcriptional activation (5, 6, 47), and SF1/Egr-1 synergistic activation of the LHβ gene promoter (25; LHβ is a natural DAX-1 target gene).”
BackgroundChristensen, B., Arbour, L. T., Tran, P. V., Leclerc, D., Sabbaghian, N., Platt, R. W., Gilfix, B. M., Rosenblatt, D. S., Gravel, R. A., Forbes, P. A., et al. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990521)84:2<94::aid-ajmg3>3.0.co;2-1 · Cited by 305
Habiby, R. L., Boepple, P., Nachtigall, L., Sluss, P. M., Crowley, W. F., & Jameson, J. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118866 · Cited by 257 · cited 3×
“It remains debatable whether HHG associated with DAX1 mutations results from hypothalamic or pituitary dysfunction (9, 12, 29, 34).”
BackgroundSelf-citationBa2+ inhibition of VIP- and A23187-stimulated Cl- secretion by T84 cell monolayers
Mandel, K. G., McRoberts, J. A., Beuerlein, G., Foster, E. S., & Dharmsathaphorn, K. (1986) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1986.250.3.c486 · Cited by 251
A Transcriptional Silencing Domain in DAX-1 Whose Mutation Causes Adrenal Hypoplasia Congenita
Lalli, E. (1997) · Molecular Endocrinology · doi:10.1210/me.11.13.1950 · Cited by 199 · cited 6×
“A schematic representation of the DAX-1 mutants studied is shown in Figure 4a. Fusion proteins containing the DAX-1 LBD linked to a GAL4 DBD were used to study the effect of DAX-1 and its mutants on basal transcriptional activity of the UAS-TK109luc reporter (Figure 4b).”
BackgroundInfluentialPanning transfected cells for electrophysiological studies.
Margolskee, R. F., McHendry‐Rinde, B., & HORN, R. C. V. (1993) · PubMed · Cited by 186
Guo, W. W., Burris, T. P., & Mccabe, E. R. B. (1995) · Biochemical and Molecular Medicine · doi:10.1006/bmme.1995.1049 · Cited by 180 · cited 3×
“The coexpression of DAX-1 with SF-1 in the gonadal and adrenal axes (2, 3), and the adrenal failure seen in patients with mutations in these genes (11, 42), suggest that DAX-1 and SF-1 interact in a common genetic pathway.”
BackgroundDAX-1 Blocks Steroid Production at Multiple Levels1
Lalli, E., Melner, M. H., Stocco, D. M., & Sassone-Corsi, P. (1998) · Endocrinology · doi:10.1210/endo.139.10.6217 · Cited by 177 · cited 1×
“Indeed, DAX-1 also inhibits transcription of SF-1 target genes involved in adrenal steroidogenesis, such as steroidogenic acute regulatory protein (StAR), P450scc, and 3β-hydroxysteroid dehydrogenase (43, 44).”
BackgroundDorn, C., Ou, Q., Svaren, J., Crawford, P. A., & Sadovsky, Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.20.13870 · Cited by 165
Reutens, A. T., Achermann, J. C., Ito, M., Ito, M., Gu, W.-X., Habiby, R. L., Donohoue, P. A., Pang, S., Hindmarsh, P. C., & Jameson, J. L. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5468 · Cited by 157 · cited 18×
“Although the pituitary-gonadal axis may be intact in early infancy in boys with AHC (32, 33), failure to undergo puberty due to hypogonadotropic hypogonadism is a hallmark of this condition (9, 12, 34).”
BackgroundInfluentialSelf-citationPeter, M. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.8.2666 · Cited by 157 · cited 2×
“Indeed, the age at onset of adrenal insufficiency can vary within the same family, suggesting that other epigenetic or nongenetic factors influence the clinical course of AHC (11, 13, 27, 32).”
BackgroundHormonal and developmental regulation of DAX-1 expression in Sertoli cells
Tamai, K. T. (1996) · Molecular Endocrinology · doi:10.1210/me.10.12.1561 · Cited by 132 · cited 2×
“In addition, the low serum inhibin B concentration, despite a slightly elevated serum immunoreactive FSH concentration (41), provides further evidence that DAX-1 mutations cause primary defects in Sertoli cell function (10, 39).”
BackgroundHalvorson, L. M., Ito, M., Jameson, J. L., & Chin, W. W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.24.14712 · Cited by 129 · cited 1×
“Rat early growth response 1 (Egr1) cDNA was introduced into a pCMX vector for expression of fulllength Egr-1 protein (17).”
MethodSelf-citationYu, R. N. (1998) · Molecular Endocrinology · doi:10.1210/me.12.7.1010 · Cited by 127
Self-citationCouzinet, B., Young, J., Brailly, S., Le Bouc, Y., Chanson, P., & Schaison, G. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00649.x · Cited by 112
Resistance of Hypogonadic Patients with Mutated GnRH Receptor Genes to Pulsatile GnRH Administration
Caron, P. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.3.990 · Cited by 112
Self-citationIdentification of a Putative Steroidogenic Factor-1 Response Element in the DAX-1 Promoter
Burris, T. P., Guo, W., Le, T., & McCabe, E. R. B. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2324 · Cited by 106
Diagnosis of X-linked Adrenal Hypoplasia Congenita by Mutation Analysis of the DAX1 Gene
Guo, W. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530040052040 · Cited by 106
Wolfe, M. W., & Call, G. B. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.5.0276 · Cited by 105
Nachtigall, L. B. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.10.3520 · Cited by 97 · cited 1×
“In addition, the low serum inhibin B concentration, despite a slightly elevated serum immunoreactive FSH concentration (41), provides further evidence that DAX-1 mutations cause primary defects in Sertoli cell function (10, 39).”
BackgroundDAX1 Mutations Map to Putative Structural Domains in a Deduced Three-Dimensional Model
Zhang, Y.-H., Guo, W., Wagner, R. L., Huang, B.-L., McCabe, L., Vilain, E., Burris, T. P., Anyane-Yeboa, K., Burghes, A. H. M., Chitayat, D., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301782 · Cited by 95
Guo, W. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.7.2481 · Cited by 83
Congenital adrenal hypoplasia and isolated gonadotropin deficiency
Kletter, G. B., Gorski, J. L., & Kelch, R. P. (1991) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(91)90001-4 · Cited by 82 · cited 3×
“Affected boys develop adrenal failure shortly after birth or during early childhood, whereas HHG, a universal feature of the syndrome, is usually recognized at the expected time of puberty (9, 12, 13).”
BackgroundActive hypothalamic-pituitary-gonadal axis in an infant with X-linked adrenal hypoplasia congenita
Takahashi, T., Shoji, Y., Shoji, Y., Haraguchi, N., Takahashi, I., & Takada, G. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70217-8 · Cited by 80 · cited 14×
“Although the pituitary-gonadal axis may be intact in early infancy in boys with AHC (32, 33), failure to undergo puberty due to hypogonadotropic hypogonadism is a hallmark of this condition (9, 12, 34).”
BackgroundInfluentialNeuroendocrine Control of Human Reproduction in the Male
Crowley, W. F., Whitcomb, R. W., Jameson, J. L., Weiss, J., Finkelstein, J. S., & O'Dea, L. S. L. (1991) · Elsevier eBooks · doi:10.1016/b978-0-12-571147-0.50006-8 · Cited by 71 · cited 3×
“, Kallmann syndrome) (20, 29, 34), suggesting at least a partial pituitary component to the defect in gonadotropin production.”
BackgroundResultSelf-citationGhai, K., Cara, J. F., & Rosenfield, R. L. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.10.7559884 · Cited by 66
Nakae, J. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.10.3680 · Cited by 65
Golden, G. S. (1977) · American journal of diseases of children · doi:10.1001/archpedi.1977.02120180045008 · Cited by 57
Haplotype analysis of 94 cystic fibrosis mutations with seven polymorphic CFTR DNA markers
Morral, N., Dörk, T., Llevadot, R., Dziadek, V., Mercier, B., Férec, C., Costes, B., Girodon, E., Zielenski, J., Tsui, L., et al. (1996) · Human Mutation · doi:10.1002/(sici)1098-1004(1996)8:2<183::aid-humu12>3.0.co;2-z · Cited by 55
Yanase, T. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.2.530 · Cited by 53 · cited 14×
“Although the pituitary-gonadal axis may be intact in early infancy in boys with AHC (32, 33), failure to undergo puberty due to hypogonadotropic hypogonadism is a hallmark of this condition (9, 12, 34).”
BackgroundInfluentialWHITCOMB, R. W., O'DEA, L. S. L., FINKELSTEIN, J. S., HEAVERN, D. M., & CROWLEY, W. F. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-6-1654 · Cited by 50 · cited 2×
“Although the number of pulses was normal (19), the secretory patterns were erratic, and only 1 LH pulse and FAS pulse were coincident (20, 21).”
BackgroundResultThe Role of DAX-1 in Reproduction
Yu, R. N., Achermann, J. C., Ito, M., & Jameson, J. L. (1998) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(98)00048-4 · Cited by 45 · cited 5×
“Although the pituitary-gonadal axis may be intact in early infancy in boys with AHC (32, 33), failure to undergo puberty due to hypogonadotropic hypogonadism is a hallmark of this condition (9, 12, 34).”
BackgroundInfluentialSelf-citationNovel DAX1 mutations in X‐linked adrenal hypoplasia congenita and hypogonadotrophic hypogonadism
Bassett, J. H. D., O'Halloran, D. J., Williams, G. R., Beardwell, C. G., Shalet, S. M., & Thakker, R. V. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00601.x · Cited by 45 · cited 2×
“taneous onset of puberty has been described in 3 boys with DAX1 mutations (35).”
BackgroundNakae, J. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.11.3835 · Cited by 43
Congenital Adrenal Hypoplasia and Hypogonadotropic Hypogonadism
Golden, M. P. (1977) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1977.02120230063010 · Cited by 42 · cited 1×
“However, in all other cases reported to date, unequivocal symptoms of adrenal failure appeared before the age of 10 years (13, 28).”
BackgroundSchwartz, M., Blichfeldt, S., & Müller, J. (1996) · Human Genetics · doi:10.1007/s004390050316 · Cited by 34
Zamboni, G., Antoniazzi, F., & Tatò, L. (1995) · The Journal of Pediatrics · doi:10.1016/s0022-3476(95)70406-x · Cited by 32
Kinoshita, E., Kinoshita, E., Yoshimoto, M., Yoshimoto, M., Motomura, K., Motomura, K., Kuroda-Kawaguchi, T., Kuroda-Kawaguchi, T., Mori, R., Mori, R., et al. (1997) · Hormone Research · doi:10.1159/000185364 · Cited by 25
Gonadotrophin deficiency and adrenocortical insufficiency in children: a new syndrome.
Kelly, W. F., Joplin, G. F., & Pearson, G. W. (1977) · BMJ · doi:10.1136/bmj.2.6079.98 · Cited by 25
Abe, S., Nakae, J., Yasoshima, K., Tajima, T., Shinohara, N., Murashita, M. M., Satoh, K., Koike, A., Takahashi, Y., & Fujieda, K. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990521)84:2<87::aid-ajmg1>3.3.co;2-z · Cited by 21
Dréan, Y. L., Liu, D., Xiong, F., & Hew, C. L. (1997) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(97)00184-6 · Cited by 20
Luteinizing hormone secretory pattern before and after removal of Leydig cell tumor of the testis
Caron, P. J., Bennet, A., Plantavid, M. M., & Jp, L. (1994) · European Journal of Endocrinology · doi:10.1530/eje.0.1310156 · Cited by 14 · cited 1×
“Although the number of pulses was normal (19), the secretory patterns were erratic, and only 1 LH pulse and FAS pulse were coincident (20, 21).”
BackgroundProlonged Survival Without Therapy in Congenital Adrenal Hypoplasia
Sills, I. N. (1983) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1983.02140380046015 · Cited by 12 · cited 1×
“Rare cases of delayed onset adrenal failure (26–30), or progressive deterioration of adrenal function after an asymptomatic period during infancy have been described (31).”
BackgroundAhch and the feminine mystique
Parker, K. L., & Schimmer, B. P. (1998) · Nature Genetics · doi:10.1038/3780 · Cited by 7
Apolipoprotein E allelic frequency in elderly smokers
Bowman, E. D., Br�meke, B., Lensing, W., & Shields, P. G. (1998) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19980226)76:1<62::aid-ajmg11>3.0.co;2-n · Cited by 3
Research works printed but not linked: 19
- Yu, 1998, Mol Endocrinol, 12, 1010, 10.1210/mend.12.7.0131 · doi:10.1210/mend.12.7.0131 · Paper page
- Reutens, 1999, J Clin Endocrinol Metab, 84, 504
- Groome, 1996, J Clin Endocrinol Metab, 81, 1401
- Caron, 1999, J Clin Endocrinol Metab, 84, 990, 10.1210/jcem.84.3.5518 · doi:10.1210/jcem.84.3.5518 · Paper page
- Margolskee, 1993, Biotechniques, 15, 906
- Crowley, 1991, Recent Prog Horm Res, 47, 27
- Wolfe, 1999, Mol Endocrinol, 13, 752
- Nakae, 1997, J Clin Endocrinol Metab, 82, 3835, 10.1210/jcem.82.11.4342 · doi:10.1210/jcem.82.11.4342 · Paper page
- Yanase, 1996, J Clin Endocrinol Metab, 81, 530
- Sills, 1983, Am J Dis Child, 137, 1186
- Peter, 1998, J Clin Endocrinol Metab, 83, 2666, 10.1210/jcem.83.8.5027 · doi:10.1210/jcem.83.8.5027 · Paper page
- Seminara, 1998, Endocr Rev, 19, 521
- Ghai, 1995, J Clin Endocrinol Metab, 80, 2980
- Tamai, 1996, Mol Endocrinol, 10, 1561
- Nachtigall, 1996, J Clin Endocrinol Metab, 81, 3520
- Lalli, 1997, Mol Endocrinol, 11, 1950, 10.1210/mend.11.13.0038 · doi:10.1210/mend.11.13.0038 · Paper page
- Guo, 1996, J Clin Endocrinol Metab, 81, 2481
- Nakae, 1996, J Clin Endocrinol Metab, 81, 3680
- Abe, 1999, Am J Med Genet, 84, 87, 10.1002/(SICI)1096-8628(19990521)84:2<87::AID-AJMG1>3.0.CO;2-7 · doi:10.1002/(sici)1096-8628(19990521)84:2<87::aid-ajmg1>3.0.co;2-7
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
10.1016/b978-1-4160-2911-3.50026-1
(2000) · CrossRef Listing of Deleted DOIs · doi:10.1016/b978-1-4160-2911-3.50026-1 · Cited by 554
Beranova, M., Oliveira, L. M. B., Bédécarrats, G. Y., Schipani, E., Vallejo, M., Ammini, A. C., Quintos, J. B., Hall, J. E., Martin, K. A., Hayes, F. J., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.4.7395 · Cited by 216
DAX-1 (NR0B1) and steroidogenic factor-1 (SF-1, NR5A1) in human disease
Suntharalingham, J. P., Buonocore, F., Duncan, A. J., & Achermann, J. C. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.07.004 · Cited by 231
Self-citationLin, L., Gu, W.-X., Ozisik, G., To, W. S., Owen, C. J., Jameson, J. L., & Achermann, J. C. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0603 · Cited by 210
“It also seems likely that an intrinsic defect in spermatogenesis, which may be present in humans as well as mice, results in a worse fertility prognosis for individuals with X-linked AHC compared with young men with isolated idiopathic HH (8, 19, 20).”
BackgroundSelf-citation
Metadata
- Authors
- Tabarin, A., Achermann, J. C., Recan, D., Bex, V., Bertagna, X., Christin-Maitre, S., Ito, M., Jameson, J. L., & Bouchard, P.
- Affiliations
- Centre Hospitalier Universitaire de Bordeaux (FR)
- Northwestern University (US)
- Hôpital Cochin (FR)
- Hôpital Saint-Antoine (FR)
- Corresponding author
- Tabarin, Antoine
- Venue
- Journal of Clinical Investigation
- Published
- 2000-02-01
- Volume
- 105
- Issue
- 3
- Pages
- 321-328
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC377437
- OpenAlex
- W2168933737
- Cited by
- 187
- References
- 59
- Citations by year
- 2026: 1 · 2024: 2 · 2023: 5 · 2022: 5 · 2021: 3 · 2020: 5 · 2019: 8 · 2018: 7 · 2017: 5 · 2016: 6 · 2015: 4 · 2014: 7 · 2013: 5 · 2012: 5
- FWCI
- 10.90
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- National Institutes of Health
- National Center for Research Resources (MO1-RR-00048, M01RR000048)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD29164, U54HD029164)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
- Keywords
- DAX-1, NR0B1, X-linked adrenal hypoplasia congenita, spermatogenesis, oligozoospermia, pubertal development, clinical phenotype spectrum
- MeSH terms
- Adrenal Glands, Adult, Animals, DNA-Binding Proteins, Humans, Hypogonadism, Male, Mutation, Repressor Proteins, Transcription Factors, Age of Onset, Receptors, Retinoic Acid, Mice, Knockout, Mice, DAX-1 Orphan Nuclear Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.